Diabetes

Pharmacists can play an integral role in managing patients with diabetes.

The successful maiden flight of an autonomous drone delivering insulin shows the potential for drone use in the delivery of lifesaving medications and supplies during disasters.

A clinical trial funded by AstraZeneca evaluated the use of short-acting GLP-1 receptor agonists as an add-on treatment to insulin therapy in type 1 diabetes.

Ticagrelor alone, without aspirin, reduced bleeding without increasing the cardiovascular risks.

The updated labeling recommends temporary discontinuation of SGLT2 inhibitors before scheduled surgery.

Creating a place where patients seek diabetes care and counseling.

The CDC’s 2020 National Diabetes Statistics Report outlines the current state of the disease.

Patient access to portal self-management tools through mobile devices may help significantly improve diabetes care.

The FreeStyle Libre system decreased HbA1c, increased time in glucose range, and reduced diabetes complications.

The pharmacist’s role in diabetes management is more important than ever before, given the number of patients with diabetes and the number of options available for treating them.

Novo Nordisk has fired the first “shot heard around the health care world.”

Rosiglitazone, which is used to treat type 2 diabetes, may increase the risk of heart problems.

Fresenius Kabi’s glucagon emergency kit is a cost-effective alternative to branded kit products.

The FDA posted results of its NDMA lab analysis of metformin products in the United States.

SGLT2 inhibitor therapy provided protective effects from cardiovascular (CV) events in patients with type 2 diabetes with or without established CV disease.

Eli Lilly plans to donate at least 200,000 KwikPens of its insulin to support lower-income communities.

Older adults with diabetes are experiencing declines in all-cause mortality rates, whereas younger adults continue to be affected more by the condition.

The FDA has approved semaglutide (Ozempic, Novo Nordisk) for the reduction of major adverse cardiovascular (CV) events in patients with type 2 diabetes and established CV disease.

Shingles vaccination recommended by CDC and ADCES.

Eli Lilly added additional affordability options for patients with diabetes who use certain insulin products.

Patients with diabetes now have access to more technology than ever before to help them manage the chronic disease, but the devices can be complicated for patients to use.

Prediabetes can increase the risk the risk of developing type 2 diabetes.

Insulin aspart injection (Fiasp, Novo Nordisk) has been approved for use as a new mealtime insulin option for children with diabetes.

Due to ongoing insulin affordability challenges, Novo Nordisk is offering new cost assistance options for patients with diabetes.